IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
about
Translational utility of experimental autoimmune encephalomyelitis: recent developmentsDown-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination.IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineagesIL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune EncephalomyelitisInduction and molecular signature of pathogenic TH17 cells.Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation.IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis.Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα.Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunityPerspectives of the relationship between IL-7 and autoimmune diseases.Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor α and retard its internalization from the cell surface.Th17 cells in systemic lupus erythematosus share functional features with Th17 cells from normal bone marrow and peripheral tissues.Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity.Increased (6 exon) interleukin-7 production after M. tuberculosis infection and soluble interleukin-7 receptor expression in lung tissue
P2860
Q26775820-612FBD99-A2D5-4241-A918-75B54F66102DQ33709707-6069D8E9-E98C-4D9E-903F-733800CB91EAQ33998401-863EB495-EDD6-46B4-BDEB-FBCD378220E2Q35988606-31A3A590-58C4-432A-A3E7-006B823DC504Q36283752-F3E8B317-81B6-419B-AB67-F414962F4A1AQ36315737-2069E3C6-9BB3-44CB-AD45-DD136562FEB5Q36569341-E11BC9ED-A432-4C61-AADE-B09966061076Q37085543-02361961-DDBD-496F-8F92-99B228E3BFBCQ37470336-DEB50825-5CF4-4B42-B0FD-34BB1E16EBC2Q37974525-AF5371F9-3F7C-4593-A279-92C79C698669Q38128224-3B86D92D-0D3F-4FE8-AA64-E62839C5BD2EQ39446065-02A043BB-953F-483E-85B6-492D4DD21340Q45872178-DE88A29F-3F7E-4FDF-A465-7A34DADB746FQ46686185-B12041DE-9BB2-499D-8B33-BCC6D20B0C6DQ48920345-E399B10A-67C4-4EE9-A4C6-31AF05862CE0Q57209222-73479372-83B5-456C-BE87-8F6E4CDE57AA
P2860
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@ast
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@en
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@nl
type
label
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@ast
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@en
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@nl
prefLabel
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@ast
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@en
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.
@nl
P2860
P356
P1433
P1476
IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis
@en
P2093
J J Bright
S Kanakasabai
P2860
P2888
P356
10.1038/GENE.2010.49
P577
2010-09-23T00:00:00Z
P5875
P6179
1018285853